Form 4: Gilead CFO Dickinson Reports RSU Vesting, Tax Withholding

Gilead Sciences CFO Andrew D. Dickinson reported the vesting of restricted stock units and subsequent sale of shares for tax obligations, a routine insider transaction.

Summary

• Andrew D. Dickinson, Chief Financial Officer of Gilead Sciences, Inc. (GILD), reported transactions on December 10, 2025.
• Acquired 3,693 shares of common stock upon the vesting of restricted stock units.
• Disposed of 1,745 shares of common stock at a price of $121.34 per share to cover tax withholding obligations related to the RSU vesting.
• Following these transactions, Dickinson beneficially owns 156,503 shares of Gilead Sciences common stock.
• The restricted stock units have a four-year vesting schedule, with 25% vesting on the first anniversary of the grant date and the remainder vesting 6.25% quarterly thereafter until fully vested.

Sentiment

Score: 5

Explanation: Neutral. This is a routine insider transaction related to compensation, not indicative of significant positive or negative company performance or strategic shifts.

Positives

• The vesting of restricted stock units indicates a portion of the CFO's long-term incentive compensation has matured.
• The CFO continues to hold a significant number of shares (156,503), aligning his interests with shareholders.

Negatives

• A portion of the acquired shares (1,745 shares) was sold to cover tax liabilities, which is a common practice but reduces the direct shareholding.

Stakeholder Impact

• Shareholders: Minor impact, as it's a routine compensation event. The CFO's continued significant ownership aligns interests.
• Employees: Reflects standard executive compensation practices.

Next Steps

• Future vesting of remaining restricted stock units will occur quarterly until fully vested, following the four-year schedule.

Key Dates

Keywords

Gilead Sciences, GILD, Andrew D. Dickinson, CFO, Form 4, insider transaction, restricted stock units, RSU vesting, stock ownership, tax withholding